Familiality in brain tumors

Neurology

Volumn 71, Issue 13, 2008, Pages 1015-1020

  Blumenthal, Deborah T ^a,b,c   Cannon Albright, Lisa A ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RISK; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; GLIOBLASTOMA; HISTOLOGY; HUMAN; MEDICAL RECORD REVIEW; PEDIGREE; PRIMARY TUMOR; PRIORITY JOURNAL; ADOLESCENT; ADULT; AGED; BRAIN TUMOR; GENETICS; METHODOLOGY; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PEDIGREE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UTAH;

EID: 54049096809     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000326597.60605.27     Document Type: Article

References (39)

1. Wrensch MR, Barger GR. Familial factors associated with malignant gliomas. Genet Epidemiol 1990;7:291-301.
2. Malmer B, Iselius L, Holmberg E, Collins A, Henriksson R, Gronberg H. Genetic epidemiology of glioma. Br J Cancer 2001;84:429-434.
3. Skolnick M. The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M, eds. Banbury Report No 4; Cancer incidence in defined populations. New York: Cold Spring Harbor Laboratory; 1980: 285-297.
4. Cannon L, Bishop DT, Skolnick MH, Hunt S, Lyon JL, Smart C. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surveys 1982;1:47-69.
5. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res 1994;54:2378-2385.
6. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH. Familial associations between cancer sites. Comput Biomed Res 1999;32:517-529.
7. Cannon Albright LA, Camp NJ, Farnham J, MacDonald J, Abtin K, Rowe KG. A genealogical assessment of heritable predisposition to aneurysm. J Neurosurg 2003;99:637-643.
8. Horne BD, Camp NJ, Muhlestein J, Cannon Albright LA. Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 2004; 110:3143-3148.
9. Horne BD, Camp NJ, Muhlestein JB, Cannon Albright LA. Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 2006;152:305-311.
10. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
11. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in 13q-linked kindreds. Nat Genet 1996;12:333-337.
12. Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994;8:23-26.
13. Tavtigian SV, Simard J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-180.
14. Skolnick M, Bean L, May D, Arbon V, de Nevers K, Cartwright P. Mormon demographic history: I: nuptiality and fertility of once-married couples. Population Studies 1978;32:5-19.
15. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-1608.
16. Hill JR. A survey of cancer sites by kinship in the Utah Mormon population. In: Cairns J, Lyon JL, Skolnick M, eds. Banbury Report No 4; Cancer incidence in defined populations. New York: Cold Spring Harbor Laboratory; 1980: 299-318.
17. Malecot G. Les Mathematiques de L'heredite. Paris: Mas-son; 1948.
18. American Cancer Society. Estimated new cancer cases and deaths by sex for all sites, US, 2007. Cancer Facts & Figures 2007. American Cancer Society, Inc., Surveillance Research.
19. Louis DN, von Deimling A. Hereditary tumor syndromes of the nervous system: overview and rare syndromes. Brain Pathol 1995;5:145-151.
20. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol 1997;15:2744-2758.
21. Newton HB, Rosenblum MK, Malkin MG. Turcot's syndrome flow cytometric analysis. Cancer 1991;68:1633-1639.
22. Joerger M, Koeberle D, Neumann HP, Gillessen S. Von Hippel-Lindau Disease: a rare disease important to recognize. Onkologie 2005;28:159-163.
23. Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991;64:959-961.
24. Doherty GM. Multiple endocrine neoplasia type 1. J Surg Oncol 2005;89:143-150.
25. Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991;8:253-267.
26. De Andrade M, Barnholtz JS, Amos CI, Adatto P, Spencer C, Bondy ML. Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 2001;20:258-270.
27. Chadduck WM, Netsky MG. Familial gliomas: report of four families, with chromosome studies. Neurosurgery 1982;10:445-449.
28. Heuch I, Blom GP. Glioblastoma multiforme in three family members, including a case of true multicentricity. J Neurol 1986;233:142-144.
29. Lossignol D, Grossman SA, Sheidler VR, Griffin CA, Piantadosi S. Familial clustering of malignant astrocytomas. J Neurooncol 1990;9:139-145.
30. Grossman SA, Osman M, Hruban R, Piantadosi S. Central nervous system cancers in first-degree relatives and spouses. Cancer Invest 1999;17:299-308.
31. Malmer B, Henriksson R, Grönberg H. Familial brain tumours: genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 2003;106:260-263.
32. Ikizler Y, van Meyel DJ, Ramsay DA, et al. Glioma in families. Can J Neurol Sci 1992;19:492-497.
33. Hauge M, Harvald B. Genetics in intracranial tumors. Acta Genet Stat Med 1957;7:573-591.
34. Cicuttini FM, Hurley SF, Forbes A, et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 1997;71:203-207.
35. Malmer B, Gronberg H, Bergenheim AT, Lenner P, Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiologic cohort study. Int J Cancer 1999;81:366-370.
36. Hemminki K, Li X, Collins VP. Parental cancer as a risk factor for brain tumors. Cancer Causes Control 2001;12: 195-199.
37. Malmer B, Henriksson R, Grönberg H. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology 2002;21:279-286.
38. O'Neill BP, Blondal H, Yang P, et al. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prevention 2002;11:921-924.
39. Homma T, Fukushima T, Vaccarella S, et al. Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 2006;65:846-854.